Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-01-25

FDA Approved: LIRAGLUTIDE — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva Pharmaceuticals USA, Inc.'s original application for liraglutide (NDA 022341). The decision authorizes liraglutide for the treatment of type 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

ORIG AP for LIRAGLUTIDE (LIRAGLUTIDE)